Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Over the weekend, Bristol Myers Squibb & Co (NYSE: BMY) shared preliminary data from a Phase 1 study of CC-97540 (BMS-986353), a CD19-directed CAR T Cell Therapy Manufactured Using a Next-generation ...
Hearing Notice - CIRO to Hold an Interim Appearance in the matter of Echelon Wealth Partners and Stephen Burns
TORONTO, Nov. 18, 2024 /CNW/ - An interim appearance has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization ( CIRO) pursuant to the Investment Dealer and ...